Profile: Wai-Hong Tham
Wai-Hong Tham is a dedicated researcher focusing extensively on the development and application of nanobodies in combating the SARS-CoV-2 virus. Her work in this cutting-edge field has gained recognition as vital in the global response to the COVID-19 pandemic.
Research Focus
Tham's primary research interest lies in utilizing nanobodies, which are a type of antibody fragment, to neutralize the SARS-CoV-2 virus effectively. This innovative approach offers potential for both therapeutic treatment and preventive measures against the virus.
Significant Achievements and Contributions
Under her leadership, research initiatives have advanced the understanding of how nanobodies can be harnessed to block viral entry into cells, demonstrating potential for both improving treatment options and enhancing vaccine efficacy.
Current Position and Impact
As a prominent figure in the scientific community, Wai-Hong Tham continues to lead research efforts, collaborating with various international partners to expand the understanding and scope of nanobody applications beyond COVID-19, potentially extending to other infectious diseases.
Modified: 2025/04/23